Atossa Therapeutics Inc. (ATOS) announced Loss for second quarter that decreased from the same period last year and beat the Street estimates.
The company's bottom line came in at -$6.05 million, or -$0.05 per share. This compares with -$9.83 million, or -$0.08 per share, in last year's second quarter.
Analysts on average had expected the company to earn -$0.06 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
Atossa Therapeutics Inc. earnings at a glance (GAAP) :
-Earnings (Q2): -$6.05 Mln. vs. -$9.83 Mln. last year.
-EPS (Q2): -$0.05 vs. -$0.08 last year.
For comments and feedback: editorial@rttnews.com